CHEK2 and acquired polycythemia vera: Among cases, the highest prevalence of PV was observed for CHEK2 (1.8%), ATM (0.8%), BRCA1 (0.3%), BRCA2 (0.3%), and TP53 (0.3%, Fig. 1, Table S1).